Pharmalot - STAT

Pharmalot By Ed Silverman

NIH fails to disclose enough details about drug licensing, watchdog report finds

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Pfizer asking today for emergency-use status for Covid-19 vaccine; Trump to release drug-pricing rules

Pharmalot By Ed Silverman

To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca Covid-19 vaccine shows promise in elderly; surprise rule will require insurers to estimate out-of-pocket drug costs

Pharmalot By Ed Silverman

Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs

Pharmalot By Ed Silverman

Pharmalittle: Moderna says its Covid-19 vaccine is strongly effective; cyberattacks targeted seven firms working on the coronavirus

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Fauci urges Covid-19 vaccine access for all countries; cancer trial enrollment drops notably during pandemic

Pharmalot By Ed Silverman

Pharmalittle: Trump complains of a ‘medical deep state’: Gates donates another $70 million for Covid-19 treatments

Pharmalot By Ed Silverman

Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs

Pharmalot By Ed Silverman

Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue

Pharmalot By Ed Silverman

French regulator indicted for manslaughter for failing to respond to a drug’s side effects

Pharmalot By Ed Silverman

Pharmalittle: Russia claims its Covid-19 vaccine is 92% effective; Pfizer-BioNTech vaccine to be priced below market rates

Pharmalot By Ed Silverman

FDA requires Lilly to hire consultants to monitor quality control problems at plant making Covid-19 drug

Pharmalot By Ed Silverman

Pharmalittle: FDA OKs Lilly drug for Covid-19; most Americans would get a Covid-19 shot if infection risk drops by half

Pharmalot By Ed Silverman

ViiV’s HIV prevention shot beats Gilead’s widely used pill in a study of women

Pharmalot By Ed Silverman

Pharmalittle: Pfizer’s coronavirus vaccine is 90% effective; Biden Covid-19 task force taps prominent doctors

Pharmalot By Ed Silverman

A lucrative Regeneron contract with the federal government lacks the usual taxpayer protections

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FDA commissioner wins over his critics; wholesalers and J&J close in on opioid settlement

Pharmalot By Ed Silverman

Most doctors view the Biogen Alzheimer’s drug favorably after reading briefing documents, survey finds

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca misses timetable for Covid-19 vaccine delivery; FDA reviewers react favorably to Biogen Alzheimer’s drug

Pharmalot By Ed Silverman

Abbott sues a former executive for allegedly planning to take Covid-19 diagnostics secrets to a rival

Pharmalot By Ed Silverman

Most Read

J&J supply chain exec: ‘I lose sleep’ over sending Covid-19 vaccine to lower-income countries

Federal authorities issue strong warning to pharma over speaker programs and kickbacks

STAT-Harris Poll: Most Americans won’t get a Covid-19 vaccine unless it cuts risk by half

STAT-Harris Poll: The share of Americans interested in getting Covid-19 vaccine as soon as possible is dropping

FDA vows to disclose data used to support emergency drug authorizations

House passes a bill to close a loophole in a law that gives drug makers ‘unfair’ monopolies

Pharmalittle: Pfizer launches pilot program to deliver Covid-19 vaccine; Amazon announces new online pharmacy offering

Lawmakers introduce bill to eliminate use of dogs in pharmaceutical testing

All Coverage

NIH fails to disclose enough details about drug licensing, watchdog report finds

Up and down the ladder: The latest comings and goings

Pharmalittle: Pfizer asking today for emergency-use status for Covid-19 vaccine; Trump to release drug-pricing rules

To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose

Pharmalittle: AstraZeneca Covid-19 vaccine shows promise in elderly; surprise rule will require insurers to estimate out-of-pocket drug costs

Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs

Pharmalittle: Moderna says its Covid-19 vaccine is strongly effective; cyberattacks targeted seven firms working on the coronavirus

Up and down the ladder: The latest comings and goings

Pharmalittle: Fauci urges Covid-19 vaccine access for all countries; cancer trial enrollment drops notably during pandemic

Pharmalittle: Trump complains of a ‘medical deep state’: Gates donates another $70 million for Covid-19 treatments

Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs

Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue

French regulator indicted for manslaughter for failing to respond to a drug’s side effects

Pharmalittle: Russia claims its Covid-19 vaccine is 92% effective; Pfizer-BioNTech vaccine to be priced below market rates

FDA requires Lilly to hire consultants to monitor quality control problems at plant making Covid-19 drug

Pharmalittle: FDA OKs Lilly drug for Covid-19; most Americans would get a Covid-19 shot if infection risk drops by half

ViiV’s HIV prevention shot beats Gilead’s widely used pill in a study of women

Pharmalittle: Pfizer’s coronavirus vaccine is 90% effective; Biden Covid-19 task force taps prominent doctors

A lucrative Regeneron contract with the federal government lacks the usual taxpayer protections

Up and down the ladder: The latest comings and goings

Pharmalittle: FDA commissioner wins over his critics; wholesalers and J&J close in on opioid settlement

Most doctors view the Biogen Alzheimer’s drug favorably after reading briefing documents, survey finds

Pharmalittle: AstraZeneca misses timetable for Covid-19 vaccine delivery; FDA reviewers react favorably to Biogen Alzheimer’s drug

Abbott sues a former executive for allegedly planning to take Covid-19 diagnostics secrets to a rival

Americans are spending more on specialty medicines, despite rebates given to payers